Kadmon Report issue

Founded: New York NY United States (2009)
Status: Acquired by Sanofi-Aventis (2021)

Organization Overview

First Clinical Trial
2009
NCT00086528
First Marketed Drug
2009
ribavirin (virazole)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Kadmon Corporation, LLC | Kadmon Pharmaceuticals | KADMON PHARMS LLC